Abstract: A memory device is provided. The memory device includes an array of memory cells arranged, a plurality of word lines, and a peripheral circuit configured to perform multi-pass programming on a selected row of memory cells coupled to a selected word line. The multi-pass programming includes a plurality of programming passes. Each of the programming passes includes a programming operation and a verify operation. To perform the multi-pass programming, the peripheral circuit is configured to, in a non-last programming pass of memory cells, perform a negative gate stress (NGS) operation on a memory cell in the selected row of memory cells between the programming operation and the verify operation; and at a same time, perform a NGS operation on a memory cell in an unselected row of memory cells coupled to an unselected word line of the word lines. The unselected word line is adjacent to the selected word line.

Abstract: Systems and techniques that facilitate freeze-out as a regularizer in training neural networks are presented. A system can include a memory and a processor that executes computer executable components. The computer executable components can include: an assessment component that identifies units of a neural network, a selection component that selects a subset of units of the neural network, and a freeze-out component that freezes the selected subset of units of the neural network so that weights of output connections from the frozen subset of units will not be updated for a training run.

Abstract: A chair chassis includes: a base, provided with an accommodation chamber; a backrest support; a memory stopper, disposed on the backrest support, wherein the memory stopper is provided with a first arc surface facing the base; a locking slider, slidably disposed in the accommodation chamber of the base, wherein the locking slider is provided with a second arc surface disposed opposite to the first arc surface, and a side of the locking slider is provided with a first rack; a first elastic member; and an elastic slider, slidably disposed in the accommodation chamber of the base, wherein one end of the elastic slider is provided with a second rack, wherein the second rack is meshable with the first rack. Accordingly, the chair chassis according to the embodiments of the present disclosure achieves reclination memory adjustment of a backrest of the chair.

Abstract: 2-Benzylidene hydrazinoadenosine compounds having A2A adenosine receptor agonistic activity, represented by a general Formula (I) and pharmaceutical compositions containing the same. The compounds and compositions can act as A2A adenosine receptor agonist to serve as medicaments.

Abstract: An electrically controlled chassis includes: a chassis body; an electrical control box, internally provided with an accommodation space; a drive motor, configured to control lift adjustment of the chassis of the chair and pitch adjustment of a backrest of the chair; a winding mechanism, connected to an output shaft of the drive motor; a first pull cord, reversely wound on the winding mechanism; a second pull cord, normally wound on the winding mechanism; a backrest adjustment mechanism, disposed on the chassis body, and fixedly connected to the other end of the first pull cord; and a chassis lift mechanism, disposed on the chassis body, and fixedly connected to the other end of the second pull cord.

Abstract: An armrest pad assembly includes: an armrest pad, wherein the armrest pad includes a first support section, a bendable section, and a second support section that are successively connected along a lengthwise direction of the armrest pad; wherein the armrest pad is internally provided with a first inner frame and a second inner frame, the first inner frame being fixed to the first support section, and the second inner frame being fixed to the second support section; wherein the first inner frame and the second inner frame are configured to be connected to an armrest frame of a chair, such that during upward and downward folding adjustment of the armrest frame of the chair, the first inner frame and the second inner frame drive the first support section and the second support section to be folded upward and downward about the bendable section to a predetermined position.

Abstract: The present disclosure provides 6-hydrazinoadenosine represented by the general Formula (I) and its derivatives with A2A adenosine receptor agonist activity, and pharmaceutical compositions containing them. The compound and composition can be used as A2A adenosine receptor agonists and used as medicament.

Abstract: An armrest pad assembly includes: an armrest pad, wherein the armrest pad includes a first support section, a bendable section, and a second support section that are successively connected along a lengthwise direction of the armrest pad; wherein the armrest pad is internally provided with a first inner frame and a second inner frame, the first inner frame being fixed to the first support section, and the second inner frame being fixed to the second support section; wherein the first inner frame and the second inner frame are configured to be connected to an armrest frame of a chair, such that during upward and downward folding adjustment of the armrest frame of the chair, the first inner frame and the second inner frame drive the first support section and the second support section to be folded upward and downward about the bendable section to a predetermined position.

Abstract: Techniques are provided for evaluating and defining the scope of data-driven deep learning models. In one embodiment, a machine-readable storage medium is provided comprising executable instructions that, when executed by a processor, facilitate performance of operations comprising employing a machine learning model to extract first training data features included in a training data set and first target data features included in a target data set. The operations further comprise determining whether the target data set is within a defined data scope of the training data set based on analysis of correspondences between the first training data features and the first target data feature, and determining whether application of the target data set to a target neural network model developed using the training data set will generate results with an acceptable level of accuracy based on whether the target data set is within the defined data scope.

Abstract: Disclosed are a method for automatically encrypting a short message, a storage device and a mobile terminal. The method comprises: matching a number and content of a short message respectively with a pre-set short message encryption number group and a key word database; if the matching succeeds, performing encryption processing on the short message; and distributing the short message to an application program having the authority to monitor the short message. The short message content is encrypted before the application program receives the short message, preventing important information from being maliciously stolen by the application program.

Abstract: Systems and methods to generate artificial intelligence models with synthetic data are disclosed. An example system includes a deep neural network (DNN) generator to generate a first DNN model using first real data. The example system includes a synthetic data generator to generate first synthetic data from the first real data, the first synthetic data to be used by the DNN generator to generate a second DNN model. The example system includes an evaluator to evaluate performance of the first and second DNN models to determine whether to generate second synthetic data. The example system includes a synthetic data aggregator to aggregate third synthetic data and fourth synthetic data from a plurality of sites to form a synthetic data set. The example system includes an artificial intelligence model deployment processor to deploy an artificial intelligence model trained and tested using the synthetic data set.

Abstract: The present application provides a small-molecule compound, represented by general Formula (I), having A2A adenosine receptor antagonistic activity and a pharmaceutical composition containing same. The compound and composition can be used as A2A adenosine receptor antagonistic agents.

Abstract: The present invention provides a novel antibiotic compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, an ester thereof, a prodrug thereof, a solvate thereof, or a deuterated analog thereof, or a stereoisomer thereof. The compound of the present invention exhibits excellent antibacterial activity, especially against Gram bacteria. wherein each group is defined as in the description.

Abstract: Techniques involve: acquiring, through a first downstream port of a first switch of a data storage system, information indicating an error of a storage device array from a second switch of the data storage system, wherein the first switch and the second switch are connected to the storage device array and the first downstream port is connected to a second downstream port of the second switch; executing, based on the acquired information, actual actions intended for solving the error; and in response to the executed actual actions failing to match with expected actions for the error, issuing an alarm indicating failure of processing the error.

Abstract: An electronic device includes a substrate, a polarizer, a flexible printed circuit board, a first transparent glue layer, a first colloid, and a second colloid. The substrate includes a first side and a second side. The first side is opposite to the second side. The polarizer is disposed on the first side of the substrate. The flexible printed circuit board is connected to the first side of the substrate with a conductive glue. A gap is formed between flexible circuit board and polarizer. The first transparent glue layer is disposed on the second side of substrate. The first colloid is configured to bond at least two of substrate, polarizer, or flexible printed circuit board. The second colloid is configured to bond at least two of the substrate, the flexible printed circuit board, or the first transparent glue layer. The first colloid is not in contact with the second colloid.

Abstract: A refrigerator includes a drawer in a refrigeration compartment including a support on a wall of the compartment, and a work slot oblique to a lid. The lid opens or closes the drawer and includes a protruding portion on an upper surface and a motion member on a side edge of the lid moving in the work slot. A motor module includes a cam and a motor driving the cam in first rotation, to push the protruding portion to drive the motion member to move obliquely upward along the work slot, so the lid ascends to a first position, and driving the cam in second rotation opposite the first to cause the lid to drive the motion member under gravity obliquely downward along the work slot, so the lid descends to a second position lower than the first in automatically adjustment. A method for lid adjustment is also provided.

Abstract: The present invention provides an antibody that specifically binds to proprotein convertase subtilisin/kexin type 9 (PCSK9), an antigen-binding fragment of the antibody, and a composition comprising the antibody or the fragment. Also provided are a nucleic acid that encodes the antibody or the fragment, a host cell containing the nucleic acid, and applications of the antibody and fragment in treatment and diagnosis.

Abstract: Techniques for managing a disk involve acquiring a message for an access operation for a disk, the message including a first status code at an operating system level for the access operation. The techniques further involve acquiring a second status code at a disk hardware level for the access operation if it is determined that the first status code indicates that the access operation fails. The techniques further involve determining, according to a handling policy corresponding to the second status code, whether the disk will be marked as faulty. The techniques further involve managing the disk based on a count of failed access operations for the disk if it is determined that the disk is not marked as faulty. Such techniques may quickly determine a specific reason for a failure of a disk access operation, making it possible to solve problems quickly, save time and improve the user experience.

Abstract: The present invention relates to a compound represented by Formula I, its pharmaceutically acceptable salt, its stereoisomer, its pharmaceutically acceptable hydrate or solvate, or its pharmaceutically acceptable ester, wherein R is selected from heteroaryl, substituted heteroaryl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, alkyl, and substituted alkyl, wherein the substituted heteroaryl, the substituted aryl, the substituted cycloalkyl and the substituted alkyl are each independently substituted with one or more hydroxyalkylene groups. The compound or its pharmaceutically acceptable salt, its stereoisomer, its pharmaceutically acceptable hydrate or solvate, its pharmaceutically acceptable ester of the present invention has agonistic activity on A2A adenosine receptor and can improve the permeability of blood-brain barrier to promote the delivery of drug across blood-brain barrier, and can also prevent or treat a disease associated with A2A adenosine receptor agonistic activity.